(1)
EVALUATING THE ROLE OF TUMOR MICROENVIRONMENT HETEROGENEITY IN THE PROGRESSION AND TREATMENT RESISTANCE OF PANCREATIC DUCTAL ADENOCARCINOMA. Biosci. Rep. 2026, 3 (01), 1-23.